Researchclopedia

Research Researchers Institutions Topics Submit About

Command Palette

Search for a command to run...

Researchclopedia

Research Researchers Institutions About

© 2026 Researchclopedia. Powered by OpenAlex under CC0 license.

Edward B. Garon | Researchclopedia

Back to researchers

Edward B. Garon

732

Works

55,084

Citations

76

h-index

246

i10-index

Research Topics

Lung Cancer Treatments and Mutations Cancer Immunotherapy and Biomarkers Cancer Genomics and Diagnostics

Affiliations

AstraZeneca (United Kingdom)2010–2010

University of Southern California2006–2017

Santa Monica College2024–2024

University of Science and Technology of China2022–2022

Alberta Health Services2012–2012

Top Works

Mutational landscape determines sensitivity to PD-1 blockade in non–small cell lung cancer

Naiyer A. Rizvi,Matthew D. Hellmann,et al.

20157,869 citations

Lung Cancer Diagnosis and Treatment

Lung Cancer Research Studies

Pembrolizumab versus docetaxel for previously treated, PD-L1-positive, advanced non-small-cell lung cancer (KEYNOTE-010): a randomised controlled trial

Roy S. Herbst,Paul Baas,et al.

20156,480 citations

Pembrolizumab plus Chemotherapy in Metastatic Non–Small-Cell Lung Cancer

Leena Gandhi,Delvys Rodríguez‐Abreu,et al.

20186,471 citations

Pembrolizumab for the Treatment of Non–Small-Cell Lung Cancer

Edward B. Garon,Naiyer A. Rizvi,et al.

20156,161 citations

Using Multiplexed Assays of Oncogenic Drivers in Lung Cancers to Select Targeted Drugs

Mark G. Kris,Bruce E. Johnson,et al.

20141,726 citations

Ramucirumab plus docetaxel versus placebo plus docetaxel for second-line treatment of stage IV non-small-cell lung cancer after disease progression on platinum-based therapy (REVEL): a multicentre, double-blind, randomised phase 3 trial

Edward B. Garon,Tudor–Eliade Ciuleanu,et al.

20141,292 citations

Patient HLA class I genotype influences cancer response to checkpoint blockade immunotherapy

Diego Chowell,Luc G.T. Morris,et al.

20171,148 citations

Updated Analysis From KEYNOTE-189: Pembrolizumab or Placebo Plus Pemetrexed and Platinum for Previously Untreated Metastatic Nonsquamous Non–Small-Cell Lung Cancer

Shirish M. Gadgeel,Delvys Rodríguez‐Abreu,et al.

20201,134 citations

Previous radiotherapy and the clinical activity and toxicity of pembrolizumab in the treatment of non-small-cell lung cancer: a secondary analysis of the KEYNOTE-001 phase 1 trial

Narek Shaverdian,Aaron Lisberg,et al.

20171,076 citations